Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Hydrocortisone therapy for patients with septic shock.

Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, Laterre PF, Reinhart K, Cuthbertson BH, Payen D, Briegel J; CORTICUS Study Group.

N Engl J Med. 2008 Jan 10;358(2):111-24. doi: 10.1056/NEJMoa071366.

2.

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Annane D, Sébille V, Charpentier C, Bollaert PE, François B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troché G, Chaumet-Riffaud P, Bellissant E.

JAMA. 2002 Aug 21;288(7):862-71. Erratum in: JAMA. 2008 Oct 8;300(14):1652. Chaumet-Riffaut, Philippe [corrected to Chaumet-Riffaud, Philippe].

PMID:
12186604
3.

Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.

Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, Hemmer B, Hummel T, Lenhart A, Heyduck M, Stoll C, Peter K.

Crit Care Med. 1999 Apr;27(4):723-32.

PMID:
10321661
4.

The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock.

Cuthbertson BH, Sprung CL, Annane D, Chevret S, Garfield M, Goodman S, Laterre PF, Vincent JL, Freivogel K, Reinhart K, Singer M, Payen D, Weiss YG.

Intensive Care Med. 2009 Nov;35(11):1868-76. doi: 10.1007/s00134-009-1603-4. Epub 2009 Aug 4.

PMID:
19652948
5.

Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial.

Arabi YM, Aljumah A, Dabbagh O, Tamim HM, Rishu AH, Al-Abdulkareem A, Knawy BA, Hajeer AH, Tamimi W, Cherfan A.

CMAJ. 2010 Dec 14;182(18):1971-7. doi: 10.1503/cmaj.090707. Epub 2010 Nov 8.

6.

Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial.

COIITSS Study Investigators, Annane D, Cariou A, Maxime V, Azoulay E, D'honneur G, Timsit JF, Cohen Y, Wolf M, Fartoukh M, Adrie C, Santré C, Bollaert PE, Mathonet A, Amathieu R, Tabah A, Clec'h C, Mayaux J, Lejeune J, Chevret S.

JAMA. 2010 Jan 27;303(4):341-8. doi: 10.1001/jama.2010.2. Erratum in: JAMA. 2010 May 5;303(17):1698.

PMID:
20103758
7.

Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock.

Oppert M, Schindler R, Husung C, Offermann K, Gräf KJ, Boenisch O, Barckow D, Frei U, Eckardt KU.

Crit Care Med. 2005 Nov;33(11):2457-64.

PMID:
16276166
8.

Reversal of late septic shock with supraphysiologic doses of hydrocortisone.

Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A.

Crit Care Med. 1998 Apr;26(4):645-50.

PMID:
9559600
9.

CAGS and ACS evidence based reviews in surgery. 35: Efficacy and safety of low-dose hydrocortisone therapy in the treatment of septic shock.

Chaudhury P, Marshall JC, Solomkin JS; Members of the Evidence Based Reviews in Surgery Group.

Can J Surg. 2010 Dec;53(6):415-7.

10.

The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial.

Gordon AC, Mason AJ, Perkins GD, Stotz M, Terblanche M, Ashby D, Brett SJ.

Crit Care Med. 2014 Jun;42(6):1325-33. doi: 10.1097/CCM.0000000000000212.

PMID:
24557425
11.

Low-dose hydrocortisone treatment for patients with septic shock: a pilot study comparing 3days with 7days.

Huh JW, Choi HS, Lim CM, Koh Y, Oh YM, Shim TS, Lee SD, Kim WS, Kim DS, Hong SB.

Respirology. 2011 Oct;16(7):1088-95. doi: 10.1111/j.1440-1843.2011.02018.x.

PMID:
21726354
12.

Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.

Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, Pogson DG, Aya HD, Anjum A, Frazier GJ, Santhakumaran S, Ashby D, Brett SJ; VANISH Investigators.

JAMA. 2016 Aug 2;316(5):509-18. doi: 10.1001/jama.2016.10485.

PMID:
27483065
13.
14.

Physiological-dose steroid therapy in sepsis [ISRCTN36253388].

Yildiz O, Doganay M, Aygen B, Güven M, Keleştimur F, Tutuû A.

Crit Care. 2002 Jun;6(3):251-9. Epub 2002 Apr 19.

15.
16.

Effect of stress doses of hydrocortisone on S-100B vs. interleukin-8 and polymorphonuclear elastase levels in human septic shock.

Mussack T, Briegel J, Schelling G, Biberthaler P, Jochum M.

Clin Chem Lab Med. 2005;43(3):259-68.

PMID:
15843228
17.

Adrenal insufficiency in patients with cirrhosis and septic shock: Effect of treatment with hydrocortisone on survival.

Fernández J, Escorsell A, Zabalza M, Felipe V, Navasa M, Mas A, Lacy AM, Ginès P, Arroyo V.

Hepatology. 2006 Nov;44(5):1288-95.

PMID:
17058239
18.

Diagnosis of corticosteroid insufficiency in Thai patients with septic shock.

Ratanarat R, Promsin P, Srivijitkamol A, Leemingsawat C, Permpikul C.

J Med Assoc Thai. 2010 Jan;93 Suppl 1:S187-95.

PMID:
20364574
19.

Drotrecogin alfa (activated) in adults with septic shock.

Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, Finfer S, Gårdlund B, Marshall JC, Rhodes A, Artigas A, Payen D, Tenhunen J, Al-Khalidi HR, Thompson V, Janes J, Macias WL, Vangerow B, Williams MD; PROWESS-SHOCK Study Group.

N Engl J Med. 2012 May 31;366(22):2055-64. doi: 10.1056/NEJMoa1202290. Epub 2012 May 22.

20.

Evaluating the efficacy and safety of two doses of the polyclonal anti-tumor necrosis factor-α fragment antibody AZD9773 in adult patients with severe sepsis and/or septic shock: randomized, double-blind, placebo-controlled phase IIb study*.

Bernard GR, Francois B, Mira JP, Vincent JL, Dellinger RP, Russell JA, Larosa SP, Laterre PF, Levy MM, Dankner W, Schmitt N, Lindemann J, Wittebole X.

Crit Care Med. 2014 Mar;42(3):504-11. doi: 10.1097/CCM.0000000000000043.

PMID:
24335445
Items per page

Supplemental Content

Write to the Help Desk